Balchem Co. (NASDAQ:BCPC) Shares Sold by Swiss National Bank

Swiss National Bank decreased its stake in shares of Balchem Co. (NASDAQ:BCPCGet Rating) by 0.4% in the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 76,300 shares of the basic materials company’s stock after selling 300 shares during the period. Swiss National Bank’s holdings in Balchem were worth $9,899,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Pictet Asset Management SA increased its position in Balchem by 16.4% during the second quarter. Pictet Asset Management SA now owns 264,355 shares of the basic materials company’s stock worth $34,297,000 after purchasing an additional 37,173 shares during the last quarter. Lazard Asset Management LLC increased its position in Balchem by 4.6% during the second quarter. Lazard Asset Management LLC now owns 10,411 shares of the basic materials company’s stock worth $1,350,000 after purchasing an additional 458 shares during the last quarter. TownSquare Capital LLC acquired a new stake in shares of Balchem in the second quarter worth $234,000. Texas Permanent School Fund increased its position in shares of Balchem by 1.3% in the second quarter. Texas Permanent School Fund now owns 23,245 shares of the basic materials company’s stock worth $3,016,000 after acquiring an additional 288 shares in the last quarter. Finally, Zions Bancorporation N.A. increased its position in shares of Balchem by 22.3% in the second quarter. Zions Bancorporation N.A. now owns 6,788 shares of the basic materials company’s stock worth $881,000 after acquiring an additional 1,236 shares in the last quarter. Institutional investors and hedge funds own 89.15% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently issued reports on BCPC. HC Wainwright dropped their price objective on shares of Balchem from $164.00 to $152.00 and set a “buy” rating for the company in a research report on Monday, November 7th. StockNews.com began coverage on shares of Balchem in a research report on Wednesday, October 12th. They issued a “hold” rating for the company.

Balchem Price Performance

BCPC opened at $141.66 on Monday. The company has a fifty day simple moving average of $130.59 and a 200 day simple moving average of $128.43. The firm has a market cap of $4.55 billion, a price-to-earnings ratio of 42.29 and a beta of 0.64. Balchem Co. has a twelve month low of $110.15 and a twelve month high of $174.29. The company has a current ratio of 2.59, a quick ratio of 1.61 and a debt-to-equity ratio of 0.54.

About Balchem

(Get Rating)

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.

Recommended Stories

Want to see what other hedge funds are holding BCPC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Balchem Co. (NASDAQ:BCPCGet Rating).

Institutional Ownership by Quarter for Balchem (NASDAQ:BCPC)

Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.